Evidence map›Paper›PMID 22053912›Full record

ArticleChemical research in toxicology2012

Aldo-keto reductases protect lung adenocarcinoma cells from the acute toxicity of B[a]P-7,8-trans-dihydrodiol.

Zahidur Abedin, Sushmita Sen, Jeffrey Field

Abstract read
In one paragraph

Article in Chemical research in toxicology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.1field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 20 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Zahidur AbedinDepartment of Pharmacology, Centers for Excellence in Environmental Toxicology and Cancer Pharmacology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104-6084, United States.
Sushmita Sen
Jeffrey Field
University of Pennsylvania · US

Funding

Translational Research Support CoreP30ES013508 · NIEHS · UNIVERSITY OF PENNSYLVANIA · PI Rebecca A Simmons · 2006 to 2026
$35.3M
Role of Pak kinases in survival and motilityR01GM048241 · NIGMS · UNIVERSITY OF PENNSYLVANIA · PI FIELD, JEFFREY M · 1992 to 2010
$3.3M
Mutagenesis of p53 by reactive PAH and ROSR01ES015662 · NIEHS · UNIVERSITY OF PENNSYLVANIA · PI FIELD, JEFFREY M · 2008 to 2012
$1.6M
Summer Mentorship in Environmental Health Sciences for High School and UndergraduR25ES016146 · NIEHS · UNIVERSITY OF PENNSYLVANIA · PI FIELD, JEFFREY M · 2008 to 2012
$311k
NIEHS NIH HHS P30 ES013508NIEHS NIH HHS R01 ES015662NIEHS NIH HHS R25 ES016146NIGMS NIH HHS R01 GM048241NIGMS NIH HHS R01 GM48241PHS HHS R01015662
6 · The paper itself

Abstract

Tobacco smoke exposure stimulates the expression of genes that are likely to be involved in the metabolism of its combustion products such as polycyclic aromatic hydrocarbons (PAH). Four of the smoke induced genes are aldo-keto reductases (AKR), enzymes that metabolically activate PAH to PAH o-quinones. Alternatively, PAHs are metabolized to (±)-anti-diol epoxides, such as (±)-anti-benzo[a]pyrene diol epoxide ((±)-anti-BPDE)), by the combined action of P4501A1/1B1 and epoxide hydrolase. (±)-anti-BPDE forms DNA adducts directly, while PAH o-quinones cause DNA damage by oxidative stress through a futile redox cycle. To address the role of AKRs in PAH cytotoxicity, we compared the cytotoxicity of PAH metabolites and the effects of overexpressing AKR1A1 in lung cells. (±)-anti-BPDE and B[a]P-7,8-trans-dihydrodiol, an intermediate in (±)-anti-BPDE metabolism, are toxic to A549 cells at concentrations with an IC(50) of ∼2 μM. In contrast, the PAH o-quinone B[a]P-7,8-dione was about 10-fold less toxic to A549 cells with an IC(50) > 20 μM. Similar differences in cytoxicity were observed with two other PAH o-quinones (benz[a]anthracene-3,4-dione and 7,12-dimethylbenz[a]anthracene-3,4-dione) compared with their respective diol-epoxide counterparts (BA-3,4-diol-1,2-epoxide and DMBA-3,4-diol-1,2-epoxide). In addition, both anti-BPDE and B[a]P-7,8-trans-dihydrodiol induced p53 expression ∼6 h post-treatment at concentrations as low as 1 μM consistent with extensive DNA damage. B[a]P-7,8-dione treatment did not induce p53 but generated reactive oxygen species (ROS) in A549 cells and induced the expression of oxidative response genes in H358 cells. We also observed that overexpression of AKR1A1 in H358 cells, which otherwise have low levels of AKR expression, protected cells 2-10-fold from the toxic effects of B[a]P-7,8-trans-dihydrodiol. These data suggest that overexpression of AKRs may protect lung cancer cells from the acute toxic effects of PAH.

Indexed as

7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxideAdenocarcinomaAdenocarcinoma of LungAlcohol OxidoreductasesAldehyde ReductaseAldo-Keto ReductasesBenzo(a)pyreneCell Line, TumorDihydroxydihydrobenzopyrenesEpithelial CellsHeme Oxygenase-1HumansLung NeoplasmsQuinonesReactive Oxygen SpeciesReal-Time Polymerase Chain Reaction7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxideAlcohol OxidoreductasesAldehyde ReductaseAldo-Keto ReductasesBenzo(a)pyrenebenzo(a)pyrene 7,8-dihydrodiolDihydroxydihydrobenzopyrenesHeme Oxygenase-1QuinonesReactive Oxygen SpeciesRNA, Messenger

Identifiers

PMID22053912
PMCPMC3261375
OpenAlexW2025121026

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.